Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» ABP-501
ABP-501
FDA panel to review Humira, Enbrel biosimilars this week
BioPharma Dive
Tue, 07/12/16 - 09:22 am
FDA
advisory panels
Humira
Enbrel
biosimilars
ABP-501
Amgen
AbbVie
GP2015
Novartis